These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17912359)

  • 1. Conservation, variability and the modeling of active protein kinases.
    Knight JD; Qian B; Baker D; Kothary R
    PLoS One; 2007 Oct; 2(10):e982. PubMed ID: 17912359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in designing substrate-competitive protein kinase inhibitors.
    Han KC; Kim SY; Yang EG
    Curr Pharm Des; 2012; 18(20):2875-82. PubMed ID: 22571656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protein kinase activity modulation sites: mechanisms for cellular regulation - targets for therapeutic intervention.
    Engh RA; Bossemeyer D
    Adv Enzyme Regul; 2001; 41():121-49. PubMed ID: 11384741
    [No Abstract]   [Full Text] [Related]  

  • 4. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
    Verkhivker GM
    Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation loop sequences confer substrate specificity to phosphoinositide 3-kinase alpha (PI3Kalpha ). Functions of lipid kinase-deficient PI3Kalpha in signaling.
    Pirola L; Zvelebil MJ; Bulgarelli-Leva G; Van Obberghen E; Waterfield MD; Wymann MP
    J Biol Chem; 2001 Jun; 276(24):21544-54. PubMed ID: 11278889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling bone marrow toxicity using kinase structural motifs and the inhibition profiles of small molecular kinase inhibitors.
    Olaharski AJ; Bitter H; Gonzaludo N; Kondru R; Goldstein DM; Zabka TS; Lin H; Singer T; Kolaja K
    Toxicol Sci; 2010 Nov; 118(1):266-75. PubMed ID: 20810542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis.
    Huang D; Zhou T; Lafleur K; Nevado C; Caflisch A
    Bioinformatics; 2010 Jan; 26(2):198-204. PubMed ID: 19942586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Phosphosites to Kinases.
    Munk S; Refsgaard JC; Olsen JV; Jensen LJ
    Methods Mol Biol; 2016; 1355():307-21. PubMed ID: 26584935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an oriented peptide library to determine the optimal substrates of protein kinases.
    Songyang Z; Blechner S; Hoagland N; Hoekstra MF; Piwnica-Worms H; Cantley LC
    Curr Biol; 1994 Nov; 4(11):973-82. PubMed ID: 7874496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exceptional disfavor for proline at the P + 1 position among AGC and CAMK kinases establishes reciprocal specificity between them and the proline-directed kinases.
    Zhu G; Fujii K; Belkina N; Liu Y; James M; Herrero J; Shaw S
    J Biol Chem; 2005 Mar; 280(11):10743-8. PubMed ID: 15647260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting aurora2 kinase in oncogenesis: a structural bioinformatics approach to target validation and rational drug design.
    Vankayalapati H; Bearss DJ; Saldanha JW; Muñoz RM; Rojanala S; Von Hoff DD; Mahadevan D
    Mol Cancer Ther; 2003 Mar; 2(3):283-94. PubMed ID: 12657723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrogating Regulatory Mechanisms in Signaling Proteins by Allosteric Inhibitors and Activators: A Dynamic View Through the Lens of Residue Interaction Networks.
    Astl L; Tse A; Verkhivker GM
    Adv Exp Med Biol; 2019; 1163():187-223. PubMed ID: 31707705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic mechanisms and regulation of protein kinases.
    Wang Z; Cole PA
    Methods Enzymol; 2014; 548():1-21. PubMed ID: 25399640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential.
    Prade L; Engh RA; Girod A; Kinzel V; Huber R; Bossemeyer D
    Structure; 1997 Dec; 5(12):1627-37. PubMed ID: 9438863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KinPred: A unified and sustainable approach for harnessing proteome-level human kinase-substrate predictions.
    Xue B; Jordan B; Rizvi S; Naegle KM
    PLoS Comput Biol; 2021 Feb; 17(2):e1008681. PubMed ID: 33556051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling.
    Dar AC; Shokat KM
    Annu Rev Biochem; 2011; 80():769-95. PubMed ID: 21548788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncovering Phosphorylation-Based Specificities through Functional Interaction Networks.
    Wagih O; Sugiyama N; Ishihama Y; Beltrao P
    Mol Cell Proteomics; 2016 Jan; 15(1):236-45. PubMed ID: 26572964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic discovery of in vivo phosphorylation networks.
    Linding R; Jensen LJ; Ostheimer GJ; van Vugt MA; Jørgensen C; Miron IM; Diella F; Colwill K; Taylor L; Elder K; Metalnikov P; Nguyen V; Pasculescu A; Jin J; Park JG; Samson LD; Woodgett JR; Russell RB; Bork P; Yaffe MB; Pawson T
    Cell; 2007 Jun; 129(7):1415-26. PubMed ID: 17570479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase activation loop autophosphorylation in cis: overcoming a Catch-22 situation.
    Lochhead PA
    Sci Signal; 2009 Jan; 2(54):pe4. PubMed ID: 19155529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel protein kinases and molecular mechanisms of autoinhibition.
    Cheetham GM
    Curr Opin Struct Biol; 2004 Dec; 14(6):700-5. PubMed ID: 15582394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.